BERKELEY, Calif., Dec. 11, 2018 /PRNewswire/ -- GenEdit, Inc., a developer of novel polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics, today announced the completion of a $8.5 million Series Seed financing round led by new investors Data Collective ...